Category
Today's News
More News
Novel class of once-weekly insulin as effective as daily injections for patients with type 2 diabetes, new study finds

Novel class of once-weekly insulin as effective as daily injections for patients with type 2 diabetes, new study finds

byDiabetologiaCredit: Unsplash/CC0 Public DomainNew researchpublishedinNew England Journal of Medicineand presented at this year's Annual Meeting of the European Asso

Novel class of once-weekly insulin as effective as daily injections for patients with type 2 diabetes, new study finds

byDiabetologiaCredit: Unsplash/CC0 Public DomainNew researchpublishedinNew England Journal of Medicineand presented at this year's Annual Meeting of the European Asso
Australian study finds medications for alcohol use disorders underutilized

Australian study finds medications for alcohol use disorders underutilized

byUniversity of Western Australia(A) Temporal trends in incident Australian adults dispensed an alcohol pharmacotherapy (2013–2023) by (B) sex, and (C) age group. Credit:Alcohol and Alcoho

Australian study finds medications for alcohol use disorders underutilized

byUniversity of Western Australia(A) Temporal trends in incident Australian adults dispensed an alcohol pharmacotherapy (2013–2023) by (B) sex, and (C) age group. Credit:Alcohol and Alcoho
Tirzepatide associated with greater weight loss in women than men

Tirzepatide associated with greater weight loss in women than men

byDiabetologiaCredit: Unsplash/CC0 Public DomainAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men,

Tirzepatide associated with greater weight loss in women than men

byDiabetologiaCredit: Unsplash/CC0 Public DomainAll doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men,
Weight loss of up to 13% achieved in three months with once-a-day tablet, Phase I trial finds

Weight loss of up to 13% achieved in three months with once-a-day tablet, Phase I trial finds

byDiabetologiaCredit: Unsplash/CC0 Public DomainIndividuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according to a presentation at

Weight loss of up to 13% achieved in three months with once-a-day tablet, Phase I trial finds

byDiabetologiaCredit: Unsplash/CC0 Public DomainIndividuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, according to a presentation at
Q&A: Researchers discuss statin, metformin, and aspirin use with hepatocellular carcinoma

Q&A: Researchers discuss statin, metformin, and aspirin use with hepatocellular carcinoma

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainErik Almazan, MD, of the Department of Medicine at Brigham and Women's Hospital and Raymond T. Chung, MD, of the Liver Cente

Q&A: Researchers discuss statin, metformin, and aspirin use with hepatocellular carcinoma

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainErik Almazan, MD, of the Department of Medicine at Brigham and Women's Hospital and Raymond T. Chung, MD, of the Liver Cente
Sickle cell patients given Lactated Ringer's solution for pain improve more easily than those given normal saline

Sickle cell patients given Lactated Ringer's solution for pain improve more easily than those given normal saline

byBoston University School of MedicineCredit: National Institutes of HealthSickle cell disease is a common genetic disorder characterized by periodic occurrences of pain that occur repeatedly th

Sickle cell patients given Lactated Ringer's solution for pain improve more easily than those given normal saline

byBoston University School of MedicineCredit: National Institutes of HealthSickle cell disease is a common genetic disorder characterized by periodic occurrences of pain that occur repeatedly th
Predictors for achieving, sustaining blood glucose control, weight loss with tirzepatide in adults with type 2 diabetes

Predictors for achieving, sustaining blood glucose control, weight loss with tirzepatide in adults with type 2 diabetes

byDiabetologiaCredit: Pixabay/CC0 Public DomainThe phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better than insulin glargine

Predictors for achieving, sustaining blood glucose control, weight loss with tirzepatide in adults with type 2 diabetes

byDiabetologiaCredit: Pixabay/CC0 Public DomainThe phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better than insulin glargine
Off-label drugs prescribed for breathlessness may do more harm than good, warn scientists

Off-label drugs prescribed for breathlessness may do more harm than good, warn scientists

byKing's College LondonCredit: Puwadon Sang-ngern from PexelsA new study from King's College London shows that off-label prescriptions of a common antidepressant doesn't help breathl

Off-label drugs prescribed for breathlessness may do more harm than good, warn scientists

byKing's College LondonCredit: Puwadon Sang-ngern from PexelsA new study from King's College London shows that off-label prescriptions of a common antidepressant doesn't help breathl
Understanding the how and why of preterm brain injury

Understanding the how and why of preterm brain injury

by Rob Clancy,Hudson Institute of Medical ResearchRepresentative images of NeuN- and MAP2-positive cells in the cortical gray matter (cortex; Layer V) and caudate. Scale bar represents 50μ

Understanding the how and why of preterm brain injury

by Rob Clancy,Hudson Institute of Medical ResearchRepresentative images of NeuN- and MAP2-positive cells in the cortical gray matter (cortex; Layer V) and caudate. Scale bar represents 50μ
Week’s Top
Podcasts
... Announcement of the 2024 Nobel Prize in Physiology or Medicine Nobel Prize in Physiology or Medicine... ... AlphaFold: The making of a scientific breakthrough The inside story of the DeepMind team of scientists and engineers who created AlphaFold, an AI system that is recognised as a solution to "p... ... Announcement of the 2024 Nobel Prize in Chemistry The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024 with one half to David Baker, University of Was...